2019
DOI: 10.5334/ijic.s3656
|View full text |Cite
|
Sign up to set email alerts
|

Enhancing cancer care guideline development and implementation using formal guideline adaptation: methodology description

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 1 publication
0
2
0
Order By: Relevance
“…Disconnections between the guideline recommendations and ‘real’ clinical practice (applicability issue) were identified as one of the frequently reported barriers, which could be partly addressed by using a collaborative model of codesign and coproduction (involving clinical personnel and end-users such as PCPs, managers, patients in the guideline development process). 41 In addition, a detailed description of the recommendations such as the dosage of the intervention (frequency, intensity and duration) could be another strategy to overcome the barrier of lack of clarity, specificity and applicability of CPGs. 27 30 The collaborative partnerships between researchers and clinical personnel and end-users can transcend the boundaries between research and real world, as well as promote the compatibility of the recommendations with real practice.…”
Section: Discussionmentioning
confidence: 99%
“…Disconnections between the guideline recommendations and ‘real’ clinical practice (applicability issue) were identified as one of the frequently reported barriers, which could be partly addressed by using a collaborative model of codesign and coproduction (involving clinical personnel and end-users such as PCPs, managers, patients in the guideline development process). 41 In addition, a detailed description of the recommendations such as the dosage of the intervention (frequency, intensity and duration) could be another strategy to overcome the barrier of lack of clarity, specificity and applicability of CPGs. 27 30 The collaborative partnerships between researchers and clinical personnel and end-users can transcend the boundaries between research and real world, as well as promote the compatibility of the recommendations with real practice.…”
Section: Discussionmentioning
confidence: 99%
“… 18 , 24 , 35–37 Engaging end-users in co-design can optimise the compatibility of GItools with the realities of clinical practice. 38 , 39 Co-design ensures recommendations are not only based on evidence for therapeutic effects but also consider practical implementation factors such as cost, time, clinical utility, and convenience. 40 …”
Section: Discussionmentioning
confidence: 99%